- Home
- Industry Reports
- Healthcare
- Medical Devices
- Global Contraceptives Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Contraceptives are also known as fertility control which is a drug that prevents pregnancy. The most effective methods of birth control are sterilization using vasectomy in males and tubal ligation in females, intrauterine devices, and implantable birth control. Contraceptive drugs are of three types of oral contraceptives, injectable contraceptives and topical contraceptives.
Global Contraceptives Market Size & Growth:
The global contraceptives market is estimated to reach at $38.14 Billion by 2025 at a CAGR of 6.8% from $25.70 Billion in 2019 during 2019-2025. The significant factors responsible for the growth are a rise in awareness of modern contraception, cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies, and growing incidence of the sexually transmitted diseases (STDs). Also, favourable regulatory scenario and awareness programs, effective contraception, fewer side effects of IUCDs and conceivable non-contraception health benefits are also contributing to the market growth.
Health risks associated with the use of contraceptive methods, religious and cultural opposition towards contraceptive methods, stringent regulations and reimbursement policies, lack of awareness and constrained access in developing economies are major restraints hindering the growth of the market. The rise in disposable income and demand for healthy life and presence of large unmet contraceptive needs in emerging Asian and African economies are creating major opportunities to the contraceptives market during the forecast period 2019-2025
Global Contraceptives Market Segments Share:
The global contraceptives market is segmented based on the product, age group, education, distribution channel, end user and geography. By product, the market is classified into contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives hold the largest market share in the contraceptives market is owing to the widespread use of oral pills by women because they are proven to be highly effective up to 99% in preventing pregnancy. Contraceptive devices are categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. Among these, condoms hold the largest market share, and IUD’s are expected to grow faster pace during the forecast period 2019-2025. By age group, the market is categorized into 15-24, 25-34, 35-44, and above 44.
By education, the global contraceptives market is segregated into less than high school, high school graduate, college graduate and others. By distribution channel, hospital pharmacy, independent pharmacy and online platforms. Independent pharmacy segment is expected to register highest CAGR in global contraceptives market due to cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies. Hospital pharmacies hold largest market share in global contraceptives market due to effective contraception and fewer side effects of IUCDs and conceivable non-contraception health benefits.
By end user, the global contraceptives market is classified into households, clinics and hospitals. Among these, household segment holds the largest market share in the global contraceptives market due to widespread consumption of oral pills and condoms to prevent unintended pregnancy and STI’s. Hospitals segment is estimated to register the highest growth in the global contraceptives market due to effective contraception and fewer side effects of IUCD’s.
By geography, the global contraceptives market is segmented into North America, South America, Asia Pacific, Europe, Middle East and Africa. North America region holds the largest market share in the global contraceptives market due to the presence of sophisticated healthcare facilities and the growing demand for contraceptives for preventing unwanted pregnancies, and favourable regulatory scenario. Asia Pacific is estimated to register highest CAGR in global contraceptives market due to rising prevalence of STDs, increasing awareness campaigns to raise awareness about contraceptives and several government initiatives.
Global Contraceptives Market Trends:
- Virginia launches $6 Million contraceptives initiative, and it will be rewarded to one dozen qualified healthcare providers to provide LARC’s to patients.
- September 2018. New fertility control pills containing both lower doses of oestrogens and newer progestogens which reduces the risk of ovarian cancer.
Global Contraceptives Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the global contraceptives market are:
- Bayer Healthcare Pharmaceuticals
- Actavis, Inc.
- Cooper Surgical, Inc.
- The Female Health Company
- Merck & Co., Inc.
Along with these companies, there were many other companies considered/ cited in the report while analysing the global contraceptives market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growth in awareness of modern contraception
4.1.2. Cumulative government initiatives and private firms to prevent unwanted abortions and
pregnancies
4.1.3. Growing incidence of sexually transmitted diseases (STDs)
4.1.4. Favourable regulatory scenario and awareness programs
4.1.5. Effective contraception and fewer side effects of IUCDs
4.2. Market Restraints & Challenges
4.2.1. Health risks associated with the use of contraceptive methods
4.2.2. Religious and cultural opposition to contraceptive methods
4.2.3. Lack of awareness and constrained access in developing economies
4.2.4. Availability of alternate contraceptive methods
4.3. Market Opportunities
4.3.1. The rise in disposable income and demand for healthy life
4.3.2. Presence of large unmet contraceptive needs in emerging Asian and African economies
CHAPTER 5 GLOBAL CONTRACEPTIVES MARKET – BY PRODUCT
5.1. Contraceptive Drugs
5.1.1. Oral Contraceptives
5.1.2. Injectable Contraceptives
5.1.3. Topical Contraceptives
5.2. Contraceptive Devices
5.2.1. Condoms
5.2.1.1. Male
5.2.1.2. Female
5.2.2. Diaphragms
5.2.3. Contraceptive Sponges
5.2.4. Vaginal Rings
5.2.5. Subdermal Implants
5.2.6. Intrauterine devices
CHAPTER 6 GLOBAL CONTRACEPTIVES MARKET – BY AGE GROUP
6.1. 15-24
6.2. 25-34
6.3. 35-44
6.4. Above 44
CHAPTER 7 GLOBAL CONTRACEPTIVES MARKET – BY EDUCATION
7.1. Less than high school
7.2. High school graduate
7.3. College graduate
7.4. Others
CHAPTER 8 GLOBAL CONTRACEPTIVES MARKET – BY DISTRIBUTION
CHANNEL
8.1. Hospital Pharmacy
8.1.1. Public
8.1.2. Private
8.2. Independent Pharmacy
8.3. Online Platforms
CHAPTER 9 GLOBAL CONTRACEPTIVES MARKET – BY END USER
9.1. House holds
9.2. Clinics
9.3. Hospitals
CHAPTER 10 GLOBAL CONTRACEPTIVES MARKET – BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL CONTRACEPTIVES MARKET – COMPANY PROFILES
11.1. Bayer Healthcare Pharmaceuticals
11.2. Actavis, Inc.
11.3. Cooper Surgical, Inc.
11.4. The Female Health Company
11.5. Merck & Co., Inc.
11.6. Mayer Laboratories, Inc.
11.7. Pfizer, Inc.
11.8. Church & Dwight, Co., Inc.
11.9. Medisafe Distribution Inc.
11.10. Teva Pharmaceutical Industries Limited
11.11. Fuji latex co. ltd
11.12. Johnson & Johnson, Ltd
11.13. Agile Therapeutics
11.14. Ani Pharmaceuticals, Inc.
11.15. Reckitt Benckiser Plc
CHAPTER 12 GLOBAL CONTRACEPTIVES MARKET – COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,504.64 - €7,513.91
- INR: ₹222,637.29 - ₹667,911.87
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,148.85 - £6,446.56
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Contraceptives are also known as fertility control which is a drug that prevents pregnancy. The most effective methods of birth control are sterilization using vasectomy in males and tubal ligation in females, intrauterine devices, and implantable birth control. Contraceptive drugs are of three types of oral contraceptives, injectable contraceptives and topical contraceptives.
Global Contraceptives Market Size & Growth:
The global contraceptives market is estimated to reach at $38.14 Billion by 2025 at a CAGR of 6.8% from $25.70 Billion in 2019 during 2019-2025. The significant factors responsible for the growth are a rise in awareness of modern contraception, cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies, and growing incidence of the sexually transmitted diseases (STDs). Also, favourable regulatory scenario and awareness programs, effective contraception, fewer side effects of IUCDs and conceivable non-contraception health benefits are also contributing to the market growth.
Health risks associated with the use of contraceptive methods, religious and cultural opposition towards contraceptive methods, stringent regulations and reimbursement policies, lack of awareness and constrained access in developing economies are major restraints hindering the growth of the market. The rise in disposable income and demand for healthy life and presence of large unmet contraceptive needs in emerging Asian and African economies are creating major opportunities to the contraceptives market during the forecast period 2019-2025
Global Contraceptives Market Segments Share:
The global contraceptives market is segmented based on the product, age group, education, distribution channel, end user and geography. By product, the market is classified into contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives hold the largest market share in the contraceptives market is owing to the widespread use of oral pills by women because they are proven to be highly effective up to 99% in preventing pregnancy. Contraceptive devices are categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. Among these, condoms hold the largest market share, and IUD’s are expected to grow faster pace during the forecast period 2019-2025. By age group, the market is categorized into 15-24, 25-34, 35-44, and above 44.
By education, the global contraceptives market is segregated into less than high school, high school graduate, college graduate and others. By distribution channel, hospital pharmacy, independent pharmacy and online platforms. Independent pharmacy segment is expected to register highest CAGR in global contraceptives market due to cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies. Hospital pharmacies hold largest market share in global contraceptives market due to effective contraception and fewer side effects of IUCDs and conceivable non-contraception health benefits.
By end user, the global contraceptives market is classified into households, clinics and hospitals. Among these, household segment holds the largest market share in the global contraceptives market due to widespread consumption of oral pills and condoms to prevent unintended pregnancy and STI’s. Hospitals segment is estimated to register the highest growth in the global contraceptives market due to effective contraception and fewer side effects of IUCD’s.
By geography, the global contraceptives market is segmented into North America, South America, Asia Pacific, Europe, Middle East and Africa. North America region holds the largest market share in the global contraceptives market due to the presence of sophisticated healthcare facilities and the growing demand for contraceptives for preventing unwanted pregnancies, and favourable regulatory scenario. Asia Pacific is estimated to register highest CAGR in global contraceptives market due to rising prevalence of STDs, increasing awareness campaigns to raise awareness about contraceptives and several government initiatives.
Global Contraceptives Market Trends:
- Virginia launches $6 Million contraceptives initiative, and it will be rewarded to one dozen qualified healthcare providers to provide LARC’s to patients.
- September 2018. New fertility control pills containing both lower doses of oestrogens and newer progestogens which reduces the risk of ovarian cancer.
Global Contraceptives Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the global contraceptives market are:
- Bayer Healthcare Pharmaceuticals
- Actavis, Inc.
- Cooper Surgical, Inc.
- The Female Health Company
- Merck & Co., Inc.
Along with these companies, there were many other companies considered/ cited in the report while analysing the global contraceptives market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growth in awareness of modern contraception
4.1.2. Cumulative government initiatives and private firms to prevent unwanted abortions and
pregnancies
4.1.3. Growing incidence of sexually transmitted diseases (STDs)
4.1.4. Favourable regulatory scenario and awareness programs
4.1.5. Effective contraception and fewer side effects of IUCDs
4.2. Market Restraints & Challenges
4.2.1. Health risks associated with the use of contraceptive methods
4.2.2. Religious and cultural opposition to contraceptive methods
4.2.3. Lack of awareness and constrained access in developing economies
4.2.4. Availability of alternate contraceptive methods
4.3. Market Opportunities
4.3.1. The rise in disposable income and demand for healthy life
4.3.2. Presence of large unmet contraceptive needs in emerging Asian and African economies
CHAPTER 5 GLOBAL CONTRACEPTIVES MARKET – BY PRODUCT
5.1. Contraceptive Drugs
5.1.1. Oral Contraceptives
5.1.2. Injectable Contraceptives
5.1.3. Topical Contraceptives
5.2. Contraceptive Devices
5.2.1. Condoms
5.2.1.1. Male
5.2.1.2. Female
5.2.2. Diaphragms
5.2.3. Contraceptive Sponges
5.2.4. Vaginal Rings
5.2.5. Subdermal Implants
5.2.6. Intrauterine devices
CHAPTER 6 GLOBAL CONTRACEPTIVES MARKET – BY AGE GROUP
6.1. 15-24
6.2. 25-34
6.3. 35-44
6.4. Above 44
CHAPTER 7 GLOBAL CONTRACEPTIVES MARKET – BY EDUCATION
7.1. Less than high school
7.2. High school graduate
7.3. College graduate
7.4. Others
CHAPTER 8 GLOBAL CONTRACEPTIVES MARKET – BY DISTRIBUTION
CHANNEL
8.1. Hospital Pharmacy
8.1.1. Public
8.1.2. Private
8.2. Independent Pharmacy
8.3. Online Platforms
CHAPTER 9 GLOBAL CONTRACEPTIVES MARKET – BY END USER
9.1. House holds
9.2. Clinics
9.3. Hospitals
CHAPTER 10 GLOBAL CONTRACEPTIVES MARKET – BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL CONTRACEPTIVES MARKET – COMPANY PROFILES
11.1. Bayer Healthcare Pharmaceuticals
11.2. Actavis, Inc.
11.3. Cooper Surgical, Inc.
11.4. The Female Health Company
11.5. Merck & Co., Inc.
11.6. Mayer Laboratories, Inc.
11.7. Pfizer, Inc.
11.8. Church & Dwight, Co., Inc.
11.9. Medisafe Distribution Inc.
11.10. Teva Pharmaceutical Industries Limited
11.11. Fuji latex co. ltd
11.12. Johnson & Johnson, Ltd
11.13. Agile Therapeutics
11.14. Ani Pharmaceuticals, Inc.
11.15. Reckitt Benckiser Plc
CHAPTER 12 GLOBAL CONTRACEPTIVES MARKET – COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.